NF-κB: A Druggable Target in Acute Myeloid Leukemia

SIMPLE SUMMARY: AML is a highly heterogeneous hematological disease and is the second most common form of leukemia. Around 40% of AML patients display elevated nuclear NF-κB activity, providing a compelling rationale for targeting the NF-κB pathway in AML. Here we summarize the main drivers of the N...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Francesco, Barbara, Verzella, Daniela, Capece, Daria, Vecchiotti, Davide, Di Vito Nolfi, Mauro, Flati, Irene, Cornice, Jessica, Di Padova, Monica, Angelucci, Adriano, Alesse, Edoardo, Zazzeroni, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319319/
https://www.ncbi.nlm.nih.gov/pubmed/35884618
http://dx.doi.org/10.3390/cancers14143557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319319/
https://www.ncbi.nlm.nih.gov/pubmed/35884618
http://dx.doi.org/10.3390/cancers14143557

Ejemplares similares